Given the high proportion of BRCA1 and 2 mutation carriers in AYA breast cancers, second cancers are a relatively common event in these women reaching about 10% contralateral breast cancer cumulative incidence in 15 years (31). The gene discussed is BRCA1; the disease is breast carcinoma.